The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to

Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned

CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a

AstraZeneca has added more details on how it will use its $15 billion budget to expand in China — and the UK pharma is betting

Collegium Pharmaceutical is beefing up its portfolio in ADHD with the acquisition of Corium’s FDA-approved drug Azstarys. The $650 million upfront deal carries up to